Snowflake (NYSE:SNOW) pioneered the data cloud, a platform that helps clients manage and make sense of big data. Of course, data is knowledge and knowledge is power, but that’s only true if you have the tools to harness data and unlock its value. And that’s become increasingly difficult as enterprises are generating data at a phenomenal pace. So Snowflake attempts to solve a critical problem.
In a somewhat surprising move, Warren Buffett’s Berkshire Hathaway invested $735 million in this high-growth tech stock around the time of its initial public offering last September. Since then, Buffett has seen big gains, and his position in Snowflake is now worth $1.5 billion.
In this Backstage Pass video, which aired on Aug. 26, 2021, Motley Fool contributors Trevor Jennewine and Brian Withers discuss Snowflake’s second-quarter earnings. Spoiler alert: The company crushed it.
Trevor Jennewine: The gist of Snowflake’s business, enterprises are creating a lot of data today and it’s spread across a lot of different systems. The idea behind snowflake is to bring all of that data together so that you can use it to make an informed business decisions, essentially. To solve the problem of data sprawl, they’ve created the data cloud, and this combines a lot of old legacy tools or point solutions like pipelines and data lakes, data warehouses.
Top Warren Buffett Stocks To Buy Right Now: Avenue Therapeutics, Inc.(ATXI)
Avenue Therapeutics, Inc., a specialty pharmaceutical company, acquires, licenses, develops, and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, which is in Phase III clinical trials to treat moderate to moderately severe post-operative pain. The company was incorporated in 2015 and is based in New York, New York.
- [By Lisa Levin] Gainers
Avenue Therapeutics, Inc. (NASDAQ: ATXI) rose 29.4 percent to $5.50 in pre-market trading after the company disclosed that its first pivotal Phase 3 trial of IV tramadol achieved the primary and key secondary endpoints.
MB Financial, Inc. (NASDAQ: MBFI) rose 16.8 percent to $51.00 in pre-market trading. Fifth Third Bancorp (NASDAQ: FITB) agreed to acquire MB Financial for $54.70 per share in cash and stock.
LiveXLive Media, Inc. (NASDAQ: LIVX) rose 9.3 percent to $5.40 in pre-market trading after falling 28.92 percent on Friday.
Celyad SA (NASDAQ: CYAD) shares rose 9 percent to $29.30 in pre-market trading after climbing 3.26 percent on Friday.
Ethan Allen Interiors Inc. (NYSE: ETH) rose 6.7 percent to $26.40 in pre-market trading after gaining 1.64 percent on Friday.
Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) rose 5.4 percent to $3.90 in pre-market trading after gaining 3.06 percent on Friday.
Acacia Communications, Inc. (NASDAQ: ACIA) rose 5.2 percent to $34.70 in pre-market trading after gaining 1.38 percent on Friday.
Westinghouse Air Brake Technologies Corporation (NYSE: WAB) rose 5.1 percent to $100 in pre-market trading. General Electric Company (NYSE: GE) agreed to merge its transportation unit with Wabtec.
Sunrun Inc. (NASDAQ: RUN) shares rose 4.7 percent to $11.50 in pre-market trading.
Nasdaq, Inc. (NASDAQ: NDAQ) shares rose 4.3 percent to $93.98 in the pre-market trading session.
LaSalle Hotel Properties (NYSE: LHO) shares rose 4.2 percent to $33.25 in pre-market trading. Blackstone Group LP (NYSE: BX) will buy LaSalle Hotel Properties in a $4.8 billion deal, Bloomberg reported.
Monro, Inc. (NASDAQ: MNRO) shares rose 4 percent to $58.35 in pre-market trading as the company posted upbeat quarterly earnings and disclosed that it has acquired Free Service Tire.
HUYA Inc. (NYSE: HUYA) rose 3.7 percent to $19.75 in pre-market trading after falling 4.80 percent on Friday.
Find out what's going
- [By Shane Hupp]
Avenue Therapeutics (NASDAQ:ATXI) released its earnings results on Thursday. The company reported ($1.03) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.69) by ($0.34), Bloomberg Earnings reports.
Top Warren Buffett Stocks To Buy Right Now: Brown Forman Corporation(BF.B)
Brown-Forman Corporation, incorporated on October 19, 1933, is a spirit and wine company. The Company manufactures, bottles, imports, exports, markets and sells a range of alcoholic beverages. The Company has a portfolio of approximately 40 spirit, wine and ready-to-drink cocktail (RTD) brands. The Company’s principal brands include Jack Daniel’s Tennessee Whiskey, Jack Daniel’s RTDs, Jack Daniel’s Tennessee Honey, Gentleman Jack Rare Tennessee Whiskey, Jack Daniel’s Tennessee Fire, Jack Daniel’s Single Barrel Collection, Jack Daniel’s Sinatra Select, Jack Daniel’s Winter Jack, Jack Daniel’s No. 27 Gold Tennessee Whiskey, Finlandia Vodkas, Finlandia RTDs, Korbel California Champagnes, Korbel California Brandy, Woodford Reserve Kentucky Bourbons, el Jimador Tequilas, el Jimador New Mix RTDs, Herradura Tequilas, Canadian Mist Canadian Whisky, Sonoma-Cutrer California Wines, Early Times Kentucky Whisky and Bourbon, Chambord Liqueur, Old Forester Kentucky Bourbon, Antiguo Tequila, Pepe Lopez Tequila, Santa Dose Cachaca and Collingwood Canadian Whisky.
The Jack Daniel’s Tennessee Whiskey is the spirit brand of any kind and the American whiskey brand. Jack Daniel’s Tennessee Honey is the flavored whiskey selling over 1.5 million nine-liter cases. The Jack Daniel’s Single Barrel Collection includes Jack Daniel’s Single Barrel Select, Jack Daniel’s Single Barrel Barrel Proof, Jack Daniel’s Single Barrel Rye and Jack Daniel’s Single Barrel 100 Proof. The Company sells its products in approximately 160 countries around the world. Its international markets include the United Kingdom, Australia, Mexico, Germany, Poland, France, Turkey, Russia, Canada and Brazil. The Company owns and operates distribution companies in approximately 13 markets, including Australia, Brazil, Canada, China, the Czech Republic, France, Germany, Hong Kong, South Korea, Mexico, Poland, Thailand and Turkey. The Company sells its products directly to retailers, to wholesalers, or, in Canada, to provincial governments.
The Company competes with Bacardi Limited, Beam Suntory Inc., Davide Campari-Milano S.p.A., Diageo PLC, LVMH Moet Hennessy Louis Vuitton SE, Pernod Ricard SA and Remy Cointreau SA.
- [By Garrett Baldwin]
Now, here’s a closer look at today’s Money Morning insight, the most important market events, and stocks to watch.
The Top Stock Market Stories for Thursday
Investors are eyeing news that the U.S. deficit with China hit a 10-year high during December. This widening deficit occurred even in the face of U.S. President Donald Trump’s large tariffs on Chinese goods. Trump has been slapping tariffs on China to reduce this deficit. However, Americans continued to buy cheap manufactured goods while the Chinese government has scooped up cheap commodities and raw materials from other nations. Yesterday, shares of Brown-Forman Corp.(NYSE: BF.B), the manufacturer of Jack Daniel’s whiskey, fell 7% after announcing the tariffs were hurting sales. Now, new tensions in the trade deal are emerging as the Chinese tech firm Huawei has sued the U.S. government over a ban to sell its equipment to the United States.
Before the bell, the European Central Bank planned to announce its latest decision on interest rates and other monetary policy matters. The ECB Bank Chief Mario Draghi hosted a press conference to discuss the bank’s forecast for the European economy. Many analysts project that several key markets – like Germany – have seen a cooldown in economic activity in recent months. The ECB has never raised interest rates during any part of Draghi’s eight-year term. The 2020 election is heating up around one issue – but it’s not the one that you think. In fact, Money Morning Special Situation Strategist Tim Melvin projects that President Trump will do something shocking before the election: legalize cannabis across the United States. Think that’s crazy? Well, you’d be amazed at how easy it would be. You’ll also be shocked by how much money you could make by getting out in front of this trend – check out Tim’s latest insight right here.
Stocks to Watch Today: KR, AMZN, PEP
Amazon.com Inc. (NASDAQ: AMZN) has learned that brick-and-mortar retail is di
- [By Garrett Baldwin]
CANNABIS UPDATE: Michigan just legalized adult-use marijuana. Three stocks to watch now.
Oil prices will be in focus as Exxon Mobil Corp. (NYSE: XOM) kicks off its annual meeting with Wall Street analysts. The firm will offer its outlook for the energy industry in the year ahead and release its 2019 financial goals. In addition, Wall Street will seek updates on the firm’s restructuring efforts in its exploration and production businesses. Johnson & Johnson (NYSE: JNJ) has received a huge boost from the U.S. Food and Drug Administration. The U.S. government has approved the first new type of antidepressant in more than 30 years. The nasal spray antidepressant is a form of esketamine, which will be sold under the brand name Spravato. Today, look for more earnings reports from BJ’s Wholesale Club Holdings Inc. (NYSE: BJ), Brown-Forman Corp. (NYSE: BF.B), Craft Brew Alliance Inc.(NASDAQ: BREW), Dollar Tree Inc. (NASDAQ: DLTR), Guidewire Software Inc. (NASDAQ: GWRE), Rosetta Stone Inc. (NYSE: RST), and Abercrombie & Fitch Co. (NYSE: ANF).
Follow Money MorningonFacebook, Twitter, and LinkedIn.
- [By Money Morning Staff Reports]
Brown Forman Corp. (NYSE: BF.B), the makers of Jack Daniels whiskey and Woodford Reserve bourbon, surged 1,830% over the last 30 years.
Wynn Resorts Ltd. (NASDAQ: WYNN), the famous Las Vegas casino operation, popped 913% since 2002.
- [By Logan Wallace]
Get a free copy of the Zacks research report on Brown-Forman (BF.B)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Top Warren Buffett Stocks To Buy Right Now: Tupperware Brands Corporation(TUP)
Tupperware Brands Corporation operates as a direct-to-consumer marketer of various products across a range of brands and categories worldwide. The company engages in the manufacture and sale of design-centric preparation, storage, and serving solutions for the kitchen and home, as well as a line of cookware, knives, microwave products, microfiber textiles, and water related items under the Tupperware brand name. It also manufactures and distributes skin and hair care products, cosmetics, bath and body care, toiletries, fragrances, jewelry, and nutritional products under the Armand Dupree, Avroy Shlain, BeautiControl, Fuller, NaturCare, Nutrimetics, and Nuvo brands. The company sells its products directly to distributors, directors, managers, and dealers. The company was formerly known as Tupperware Corporation and changed its name to Tupperware Brands Corporation in December 2005. Tupperware Brands Corporation was founded in 1996 and is headquartered in Orlando, Florida.
- [By Shane Hupp]
Tupperware Brands Co. (NYSE:TUP) has earned an average recommendation of “Hold” from the six research firms that are covering the stock, MarketBeat.com reports. Three analysts have rated the stock with a sell recommendation and three have given a hold recommendation to the company. The average 12-month price target among brokers that have issued a report on the stock in the last year is $35.67.
- [By Ethan Ryder]
Twin Capital Management Inc. boosted its position in shares of Tupperware Brands Co. (NYSE:TUP) by 2.9% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 80,930 shares of the company’s stock after acquiring an additional 2,300 shares during the period. Twin Capital Management Inc. owned 0.16% of Tupperware Brands worth $3,338,000 at the end of the most recent quarter.
- [By Joseph Griffin]
Raymond James Financial Services Advisors Inc. decreased its position in Tupperware Brands Co. (NYSE:TUP) by 13.4% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 9,126 shares of the company’s stock after selling 1,417 shares during the period. Raymond James Financial Services Advisors Inc.’s holdings in Tupperware Brands were worth $376,000 as of its most recent SEC filing.
Top Warren Buffett Stocks To Buy Right Now: RELX PLC(RELX)
RELX Group is a global provider of information and analytics for professional and business customers across industries.
Our goal is to help customers make better decisions, get better results and be more productive. We do this by leveraging a deep understanding of our customers to create innovative solutions which combine content and data with analytics and technology in global platforms.
The Group has customers in more than 180 countries and has offices in about 40 countries. The Group employs approximately 30,000 staff.
We operate in four major market segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions.
? Scientific, Technical & Medical helps customers advance science and improve healthcare by providing information and analytical solutions that enable them to make critical decisions, enhance productivity, and improve outcomes. Advisors’ Opinion:
- [By Joseph Griffin]
First Republic Investment Management Inc. acquired a new position in shares of Relx PLC (NYSE:RELX) in the 2nd quarter, Holdings Channel reports. The fund acquired 13,205 shares of the technology company’s stock, valued at approximately $287,000.
- [By Joseph Griffin]
Relx PLC (NYSE:RELX)’s share price reached a new 52-week low during mid-day trading on Tuesday . The company traded as low as $20.27 and last traded at $20.29, with a volume of 6975 shares traded. The stock had previously closed at $20.35.
- [By Joseph Griffin]
Relx (NYSE: RELX) and Cambium Learning Group (NASDAQ:ABCD) are both computer and technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, valuation, risk, profitability, dividends, earnings and analyst recommendations.
Top Warren Buffett Stocks To Buy Right Now: Bayer Aktiengesellschaft (BAYRY)
Bayer AG is a life science company. The Company’s segments are Pharmaceuticals, Consumer Health, Crop Science, Animal Health and Covestro. The Pharmaceuticals segment is engaged in the development of prescription pharmaceuticals; contraceptives, and medical products, such as injection systems and contrast agents for diagnostic procedures. The Consumer Health segment is engaged in the development of over-the-counter medications, dermatology products and nutritional supplements. The Crop Science segment is engaged in the development of product portfolio in the areas of seeds and plant traits, crop protection, home and garden, the green industry and nonagricultural pest control. The Animal Health segment is engaged in the development of veterinary medicines and animal grooming products. Covestro is engaged in the development of raw materials for polyurethanes; polycarbonate resins and sheets; raw materials for coatings, adhesives and sealants; and selected chemical intermediates.
- [By ]
Bayer (OTCPK:BAYRY) – Together with Orion Corporation, the company announced that the FDA accepted its New Drug Application and granted Priority Review for darolutamide for the treatment of non-metastatic castration-resistant prostate cancer in the United States. This decision was based on data from the phase III ARAMIS trial – recently, Bayer also submitted an application to the European Medicines Agency and the Ministry of Health, Labor and Welfare in Japan. The drug candidate is thought to have peak sales potential in excess of $1 billion.
- [By ]
Overall, investors need to rely on what is factual and can be referenced. FOTIVDA still outperforms Bayers (OTCPK:BAYRY) Nexavar in PFS and ORR. The preliminary OS data is not complete enough for the FDA and that should be acceptable for investors. In fact, the idea the company had not really addressed the issues from the previous CRL would have prevented me from entering a position prior to the PDUFA date. The market overreacted to the NDA delay news as if it was a CRL. Yes, the company has to hold off on submitting, but the management expects to file an NDA before the end of 2019; which would put the PDUFA date in the second half of 2020.
- [By Cory Renauer]
The first to earn approval, Vitrakvi, treats patients with any type of cancer, as long as their tumors test positive for a specific mutation. Bayer (NASDAQOTH:BAYRY) will market Vitrakvi and send Lilly royalties in a low-30s percentage range on U.S. sales and a tiered double-digit percentage of sales everywhere else.